ReviewFrontiers in immunology2021

Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and -γ.

Sanjay Chandrasekaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.